» Articles » PMID: 37874229

Vascular Imaging Findings in Retinopathy of Prematurity

Overview
Journal Acta Ophthalmol
Specialty Ophthalmology
Date 2023 Oct 24
PMID 37874229
Authors
Affiliations
Soon will be listed here.
Abstract

Retinopathy of prematurity (ROP) is a vascular disease among preterm infants involving incomplete or abnormal retinal vascularization and is a leading cause of preventable blindness globally. Measurements of ocular blood flow originating from a variety of imaging modalities, including colour Doppler imaging (CDI), fluorescein angiography (FA) and ocular coherence tomography angiography (OCTA), have been associated with changes in ROP patients. Herein, we discuss and summarize the relevant current literature on vascular imaging and ROP reviewed through December 2022. Differences in vascular imaging parameters between ROP patients and healthy controls are reviewed and summarized. The available data identify significantly increased peak systolic velocity (PSV) in the central retinal artery and ophthalmic artery as measured by CDI, increased vascular tortuosity as measured by FA, smaller foveal avascular zone (FAZ) as measured by FA and OCTA, and increased foveal vessel density (VD) and reduced parafoveal VD as measured by OCTA in ROP patients compared with controls. None of the above findings appear to reliably correlate with visual acuity. The studies currently available, however, are inconclusive and lack robust longitudinal data. Vascular imaging demonstrates the potential to aid in the diagnosis, management and monitoring of ROP, alongside retinal examination via indirect ophthalmoscopy and fundus photography.

Citing Articles

Retinopathy of Prematurity-Targeting Hypoxic and Redox Signaling Pathways.

Zhang L, Buonfiglio F, Fiess A, Pfeiffer N, Gericke A Antioxidants (Basel). 2024; 13(2).

PMID: 38397746 PMC: 10885953. DOI: 10.3390/antiox13020148.

References
1.
Niwald A, Gralek M . Evaluation of blood flow in the ophthalmic artery and central retinal artery in children with retinopathy of prematurity. Klin Oczna. 2006; 108(1-3):32-5. View

2.
Provis J, Leech J, Diaz C, Penfold P, Stone J, Keshet E . Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res. 1998; 65(4):555-68. DOI: 10.1006/exer.1997.0365. View

3.
Azad R, Chandra P, Khan M, Darswal A . Role of intravenous fluorescein angiography in early detection and regression of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2008; 45(1):36-9. DOI: 10.3928/01913913-20080101-03. View

4.
Patel S, Klufas M, Ryan M, Jonas K, Ostmo S, Martinez-Castellanos M . Color fundus photography versus fluorescein angiography in identification of the macular center and zone in retinopathy of prematurity. Am J Ophthalmol. 2015; 159(5):950-7.e2. PMC: 4764125. DOI: 10.1016/j.ajo.2015.01.027. View

5.
Gunay M, Tuten A, Sancak S, Celik G, Bardak H, Dincer E . Effect of Single Intravitreal Bevacizumab on Ophthalmic and Middle Cerebral Arterial Blood Flow in Retinopathy of Prematurity. Ophthalmic Res. 2016; 55(4):165-71. DOI: 10.1159/000443208. View